Elinogrel
Modify Date: 2024-04-05 00:01:45
Elinogrel structure
|
Common Name | Elinogrel | ||
|---|---|---|---|---|
| CAS Number | 936500-94-6 | Molecular Weight | 523.945 | |
| Density | 1.7±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C20H15ClFN5O5S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ElinogrelElinogrel (PRT060128) is a potent, direct acting, competitive, and reversible platelet P2Y12 antagonist (IC50=20 nM). It is orally and intravenously available and has potent antiplatelet effects[1]. |
| Name | 1-(5-chlorothiophen-2-yl)sulfonyl-3-[4-[6-fluoro-7-(methylamino)-2,4-dioxo-1H-quinazolin-3-yl]phenyl]urea |
|---|---|
| Synonym | More Synonyms |
| Description | Elinogrel (PRT060128) is a potent, direct acting, competitive, and reversible platelet P2Y12 antagonist (IC50=20 nM). It is orally and intravenously available and has potent antiplatelet effects[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 20 nM (P2Y12)[2] |
| References |
| Density | 1.7±0.1 g/cm3 |
|---|---|
| Molecular Formula | C20H15ClFN5O5S2 |
| Molecular Weight | 523.945 |
| Exact Mass | 523.018738 |
| PSA | 182.53000 |
| LogP | 3.02 |
| Index of Refraction | 1.706 |
| 2-Thiophenesulfonamide, 5-chloro-N-[[[4-[6-fluoro-1,4-dihydro-7-(methylamino)-2,4-dioxo-3(2H)-quinazolinyl]phenyl]amino]carbonyl]- |
| 5-Chloro-N-({4-[6-fluoro-7-(methylamino)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl]phenyl}carbamoyl)-2-thiophenesulfonamide |
| Elinogrel |
| UNII-915Y8E749J |